Academic Journals Database
Disseminating quality controlled scientific knowledge

Enhanced Myocardial Vascularity and Contractility by Novel FGF-1 Transgene in a Porcine Model of Chronic Coronary Occlusion

Author(s): Reza Forough | Matthew W. Miller | Mildred Mattox | Wayne Dunlap | Andy Ambrus | Rola Barhoumi | Cristine L. Heaps | Janet L. Parker

Journal: Journal of Tehran University Heart Center
ISSN 1735-8620

Volume: 3;
Issue: 4;
Start page: 197;
Date: 2008;
Original page

Keywords: Angiogenesis inducing agents | Fibroblast growth factor 1 | Ischemia | Heart | Gene therapy | Transfection

"nBackground: Angiogenesis gene therapy has long been sought as a novel alternative treatment for restoring the blood flow and improving the contractile function of the ischemic heart in selected clinical settings. Angiogenic fibroblast growth factor-1 (FGF-1) is a promising candidate for developing a promising gene therapy protocol due to its multipotent ability to stimulate endothelial cell (EC) growth, migration, and tube formation. Despite these advantages, however, FGF gene therapy has suffered setbacks mainly due to the inefficient delivery rate of the growth factor in vivo. Given the potent angiogenic effect of FGF-1, we reasoned that constitutively synthesized minute quantities of this polypeptide hormone, when empowered with the ability to escape the cellular constraint, could freely act in a paracrine/autocrine fashion on nearby existing capillary plexuses and lead to neovascularization and restoration of the blood flow to ischemic tissues for reparative purpose. "nMethods: We report the direct gene transfer of a retroviral-based mammalian expression vector encoding a secreted form of FGF-1 (sp-FGF-1) for the purpose of therapeutic angiogenesis into the porcine myocardium subjected to the surgical placement of an ameroid occluder to induce the chronic coronary occlusion of the left circumflex coronary artery (LCx) and regional myocardial ischemia. Coronary angiography, performed 3 weeks after surgery, confirmed the interruption of the blood flow in the LCx distal to the site of ameroid placement. "nResults: Immunohistochemical analysis using antibody specific to von Willebrand factor (vWF), an endothelial marker, showed a significant increase (p

Tango Rapperswil
Tango Rapperswil

     Save time & money - Smart Internet Solutions